Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

By sjmartinez • September 9, 2024

Paul MK, Choudhary MC, Heaps AL, Deo R, Moisi D, Gordon KC, Mellors JW, Moser C, Klekotka P, Landay A, Currier JS, Eron JJ, Chew KW, Smith DM, Sieg SF, Parikh UM, Li JZ; ACTIV-2/A5401 Study Team. Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response. Pathog Immun. 2024 Aug 21;9(2):79-93. doi: 10.20411/pai.v9i2.718. PMID: 39247686; PMCID: PMC11378757.

Tags: bamlanivimab, covid-19, Infectious Diseases, monoclonal antibody, pseudovirus neutralization, Publications, SARS-CoV-2

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study

Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman[...]

Bundibugyo Ebola in DR Congo and Uganda: community-centred response must be operational, not rhetorical

Mbala-Kingebeni P, Boum Y, Fallah MP, Wilson B, Belizaire MR, Hoff NA, Sprecher A, Hensley LE, Kindrachuk J, Rimoin AW. Bundibugyo Ebola in DR Congo[...]

Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIV

Appa A, Javanbakht M, Spinelli M, Heise MJ, Steiner G, Bolanos R, Okochi H, Gorbach P, Gandhi M. Hair Testing to Detect Long-term Methamphetamine Use[...]